You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML

Showing 1 - 25 of 2,911
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, MDS Trial in Tuebingen (Decitabine, Venetoclax)

Recruiting
  • AML
  • MDS
  • Tuebingen, Baden-Wuerttemberg, Germany
    University Hospital
Nov 30, 2023

AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • chidamide and azacitidine
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Sep 27, 2023

AML, Adult Trial (Pharmacoscopy, Clinical standard-of-care (physician's choice))

Not yet recruiting
  • AML, Adult
  • Pharmacoscopy
  • Clinical standard-of-care (physician's choice)
  • (no location specified)
Nov 20, 2023

Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Standard Intervention
  • Investigational Intervention
  • (no location specified)
Aug 8, 2023

Acute Myeloid Leukemia Trial (MCBC regimen, Bu/Cy regimen)

Not yet recruiting
  • Acute Myeloid Leukemia
  • MCBC regimen
  • Bu/Cy regimen
  • (no location specified)
Nov 13, 2023

AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

Not yet recruiting
  • AML/MDS
  • +2 more
  • (no location specified)
Aug 14, 2023

AML, Adult Trial (Biological characterization of AML with MECOM or atypical 3q26 rearrangements)

Not yet recruiting
  • AML, Adult
  • Biological characterization of AML with MECOM or atypical 3q26 rearrangements
  • (no location specified)
Apr 21, 2023

Assessment of Geriatric Evaluations Impact on New AML Guidance

Not yet recruiting
  • AML, Adult
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Jun 12, 2023

    AML, Adult Trial (STI-8591)

    Not yet recruiting
    • AML, Adult
    • (no location specified)
    Jul 12, 2023

    Acute Myeloid Leukemia Trial (ABBV-787)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 29, 2023

    AML, Adult, Minimal Residual Disease Trial (MRD assessment)

    Not yet recruiting
    • AML, Adult
    • Minimal Residual Disease
    • MRD assessment
    • (no location specified)
    Oct 13, 2023

    AML Trial in Berne (Image-based ex-vivo drug screening platform (pharmacoscopy))

    Recruiting
    • AML
    • Image-based ex-vivo drug screening platform (pharmacoscopy)
    • Berne, Switzerland
      Departement of Medical Oncology, University Hospital Berne
    Feb 8, 2023

    Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

    Recruiting
    • Core Binding Factor Acute Myeloid Leukemia
    • KIT Mutation-Related Tumors
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Apr 7, 2023

    Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

    Not yet recruiting
    • Acute Myeloid Leukemia
      • (no location specified)
      Sep 22, 2023

      Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

      Not yet recruiting
      • Relapsed/Refractory AML
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Mar 28, 2023

      AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

      Not yet recruiting
      • AML, Adult
      • Minimal Residual Disease
      • CD33/CLL1 dual CAR-NK cell
      • +5 more
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Aug 4, 2023

      Bortezomib, Acute Myeloid Leukemia Trial in Wuhan (DAG pre-excitation regimen with Bortezomib)

      Recruiting
      • Bortezomib
      • Acute Myeloid Leukemia
      • DAG pre-excitation regimen with Bortezomib
      • Wuhan, Hubei, China
        Zhongnan Hospital of Wuhan University
      Jul 31, 2023

      AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)

      Recruiting
      • AML, Adult
      • CLL1 CAR-NK cell injection
      • Hangzhou, Zhejiang, China
        Clinical research ethics committee of the first affiliated hospi
      Aug 30, 2023

      Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

      Recruiting
      • Acute Myeloid Leukemia Refractory
      • Acute Myeloid Leukemia, in Relapse
      • anti Tim-3/CD123 CAR-T cell therapy
      • Xuzhou, Jiangsu, China
        Kailin Xu
      Nov 4, 2023

      Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

      Not yet recruiting
      • Relapsed Acute Myeloid Leukaemia
      • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
      • (no location specified)
      Jul 4, 2023

      Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

      Not yet recruiting
      • Acute Myeloid Leukemia (AML)
      • Nantes, France
        CHU de Nantes
      Jan 24, 2023

      Immunophenotyping of Blast Cells and Immune Effector Cells in

      Completed
      • Leukemia
      • Blood and Marrow sample
      • Marseille, France
        Assistance Publique - Hopitaux de Marseille
      Jan 23, 2023

      Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Mar 15, 2023

      AML Trial in Beijing (IM23)

      Completed
      • AML
      • Beijing, China
        Xian Lu
      Jan 18, 2023

      Acute Myeloid Leukemia Trial in Hefei (RC1012 injection (allo-DNT cells))

      Recruiting
      • Acute Myeloid Leukemia
      • RC1012 injection (allo-DNT cells)
      • Hefei, Anhui, China
        The First Hospital of the University of Science and Technology o
      May 17, 2023